Shattuck Labs, Inc.

Healthcare

NASDAQ:STTK · NASDAQ Global Select

Market Cap $227.06M Beta 1.09 P/E (TTM) -10.9

$4.95 +2.33%

+$0.11 today

52W Low $0.71High $8.33

Vol 1.22M · Avg 0.69M

EPS (TTM) -$0.44Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+390.10%

Period High

$7.88

Period Low

$0.73

Latest

$4.95

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Ovid Therapeutics Inc.

NASDAQ:OVID

$306.63M

Sutro Biopharma, Inc.

NASDAQ:STRO

$277.15M

Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL

$261.61M

Artiva Biotherapeutics, Inc.

NASDAQ:ARTV

$238.39M

InflaRx N.V.

NASDAQ:IFRX

$130.04M

Connect Biopharma Holdings Limited

NASDAQ:CNTB

$125.30M

Kalaris Therapeutics Inc

NASDAQ:KLRS

$88.56M

ImageneBio Inc

NASDAQ:IMA

$63.73M

Context Therapeutics Inc.

NASDAQ:CNTX

$56.26M

Metagenomi, Inc. Common Stock

MGX

$45.74M

What is the latest STTK filing?

The latest filing shown is SC 13G dated Jun 17, 2026.

How many recent filings does STTK have?

Intrinsic Alpha currently shows 20 recent filings for STTK.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.